what are glp 1 receptor agonists ๐ง๐ต๐ฒ ๐๐ณ๐ณ๐ฒ๐ฐ๐ ๐ผ๐ณ ๐๐๐ฃ-๐ญ ๐ฅ๐ฒ๐ฐ๐ฒ๐ฝ๐๐ผ๐ฟ ๐๐ด๐ผ๐ป๐ถ๐๐๐ ๐ผ๐ป ๐๐น๐๐ฐ๐ฎ๐๐ฒ๐ฑ ๐๐ฒ๐บ๐ผ๐ด๐น๐ผ๐ฏ๐ถ๐ป ๐๐ฒ๐๐ฒ๐น๐ โฃ โฃ Randomized, placebo-controlled trials of the glucagon-like peptide-1 (GLP-1) have provided strong GLP-1 Receptor Agonists Explained for
Description
These drugs were also found to cause weight loss and have been subsequently used to treat obesity

Laboratory studies have demonstrated that GLP-1 receptor activation can reduce the production of pro-inflammatory cytokines, including tumour necrosis factor-alpha (TNF-), interleukin-6 (IL-6), and interleukin-1 beta (IL-1)

By activating GLP-1 receptors, it stimulates insulin secretion from pancreatic beta cells, leading to better glucose utilization and reduced blood sugar levels

Accessed on 9th Jan 2025

After a meal, insulin secretion is stimulated quickly and considerably in order to maintain plasma glucose concentrations within a narrow physiological range (1)
